CapsoVision, Inc. (NASDAQ: CV) is a Healthcare company (Medical - Devices) with a market capitalization of $357M. The Maz Rating grades it against the other companies in its sector.
CapsoVision, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $6.65, CapsoVision, Inc. trades at 25.5x sales and 12.7x book value. Over the last twelve months it generated about $14M of revenue and a net loss of $33M. It runs a gross margin of 49.7%, an operating margin of -212.0% and a net margin of -210.1%. It shows return on equity of -160.2%, return on invested capital of -108.7% and a free cash flow yield of -8.2%. On the balance sheet: a debt-to-equity ratio of 0.03 and a current ratio of 5.07. Over the past 52 weeks the share price ranged from $4.50 to $15.37, with a beta of -2.36.
CapsoVision, Inc. does not currently pay a dividend.
1 Wall Street analyst rating covers the stock: 1 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
It depends on the standard you follow. As of September 2026, CapsoVision, Inc. (CV) passes 3 of 5 published Shariah screening standards checked by Maz Vantage: it passes AAOIFI, S&P Global and Dow Jones, and fails MSCI and FTSE.
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 0.00% / 30% · (Cash+Inv) / Mkt Cap (36m) 6.79% / 30% · Interest income / Revenue 1.29% / 5% | Pass |
| S&P Global | Debt / Mkt Cap (36m) 0.00% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 6.79% / 33% · Receivables / Mkt Cap (36m) 0.77% / 49% · Interest income / Revenue 1.29% / 5% | Pass |
| Dow Jones | Debt / Mkt Cap (24m) 0.00% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 6.79% / 33.33% · Receivables / Mkt Cap (24m) 0.77% / 33.33% · Interest income / Revenue 1.29% / 5% | Pass |
| MSCI | Debt / Avg Assets (4Q) 0.88% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 61.7% / 33.33% · Receivables / Avg Assets (4Q) 9.58% / 33.33% · Interest income / Revenue 1.29% / 5% | Fail |
| FTSE | Debt / Total Assets 0.00% / 33.33% · (Cash+ST Inv) / Total Assets 66.4% / 33.33% · (Cash+Recv) / Total Assets 73.9% / 33.33% · Interest income / Revenue 1.29% / 5% | Fail |
It depends on the standard you follow. As of September 2026, CapsoVision, Inc. (CV) passes 3 of 5 published Shariah screening standards checked by Maz Vantage: it passes AAOIFI, S&P Global and Dow Jones, and fails MSCI and FTSE.
Yes. CapsoVision, Inc. is within every AAOIFI limit: debt and interest-bearing cash and investments under 30% of its 36-month average market cap, and interest income under 5% of revenue.
About 1.29% of each dividend: CapsoVision, Inc.'s interest income as a share of its revenue. Give that share to charity; the dividend purification calculator works it out per holding.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.